INCY लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

बेचें 9 min ago

@ $62.55

जारी किया गया: 26 Jun 2024 @ 20:52

वापसी: 0.05%

पिछला सिग्नल: Jun 25 - 23:39

पिछला सिग्नल: खरीदें

वापसी: -1.15 %

Live Chart Being Loaded With Signals

Commentary (26 Jun 2024 @ 21:01):
Our systems believe the stock currently is undervalued by 0.19% compare to its pairs and should correct upwards.

Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally...

Stats
आज की मात्रा	285 584
औसत मात्रा	3.35M
बाजार मूल्य	14.07B
EPS	$0.760 ( Q1 \| 2024-04-30 )
अगली कमाई की तारीख	( $1.140 ) 2024-08-06
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	18.96 (Sector) 42.63 (Industry) 24.32
ATR14	$0.850 (1.36%)

AADI -2.94%

ABCL 1.65%

ABCM 0.04%

ABEO -2.38%

ABIO -1.68%

ABOS 1.40%

ABSI 2.38%

ABUS -2.30%

ABVX -3.53%

ACAD -0.64%

ACER -17.95%

ACET -4.76%

ACGN 1.29%

ACHL -3.00%

ACHV -1.61%

ACIU -1.00%

ACLX -0.09%

ACRV -4.79%

ACST -1.63%

ACXP 0.28%

ADAG 4.64%

ADAP -2.91%

ADGI 0.87%

ADIL 0.54%

ADMA -2.64%

ADPT -0.30%

ADTX -3.47%

ADVM -3.91%

ADXN -1.60%

AEON -3.74%

AEZS -3.51%

AFMD -1.40%

AGEN -1.82%

AGIO -2.13%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -3.12%

AKRO -2.81%

AKTX 4.08%

AKUS 0.00%

ALBO 0.00%

ALDX -2.40%

ALEC -2.29%

ALGS -2.41%

ALKS -0.25%

ALLK -8.55%

ALLO -6.23%

ALLR -3.22%

ALNA 3.16%

ALNY 1.85%

ALPN 0.02%

ALPX 0.00%

ALRN -0.33%

ALT -9.65%

ALVR -0.56%

ALXN 0.00%

ALXO -10.82%

ALZN 4.78%

AMRN -0.31%

AMTI -3.13%

ANAB 0.84%

ANEB -1.52%

ANGN 0.00%

ANIX -1.62%

ANL -6.60%

ANNX -0.55%

ANPC -3.15%

APGE -0.91%

APGN 8.48%

APGNW 30.65%

APLM 1.56%

APLS 0.09%

APLT -4.29%

APM -1.47%

APOP 0.38%

APRE 2.29%

APTO 3.27%

APTX 3.17%

APVO 0.18%

ARAV -13.39%

ARCT -3.90%

ARDS -14.23%

ARDX -0.66%

ARGX -0.82%

ARNA 0.00%

ARPO -0.90%

ARQT -0.73%

ARTL -2.50%

ARTLW 0.00%

ARVN 5.76%

ARWR -1.56%

ASLN -5.04%

ASMB -7.14%

ASND -0.94%

ATAI -1.48%

ATHA 5.94%

ATHE 1.12%

ATHX -33.50%

ATNF 0.99%

ATOS 3.41%

ATRA -3.45%

ATXI 1.93%

ATXS -0.44%

AUPH -1.17%

AURA 1.17%

AUTL -2.01%

AVBP -2.86%

AVEO 0.00%

AVIR -0.15%

AVRO -1.41%

AVTE -5.48%

AVTX -1.25%

AVXL -2.96%

AXLA 0.00%

AXSM -1.99%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 0.98%

BCAB 2.30%

BCDA -2.07%

BCDAW -41.77%

BCEL 0.00%

BCLI 7.14%

BCRX 1.27%

BCTX 7.65%

BCTXW -16.29%

BCYC 1.33%

BDRX -4.10%

BDTX -0.43%

BEAM 0.43%

BFRA -2.91%

BGNE -2.82%

BIOR -3.79%

BIVI 2.39%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.85%

BLTE -0.62%

BLU 0.03%

BLUE -0.51%

BMEA -9.97%

BMRN 0.41%

BNOX -2.22%

BNTC -2.11%

BNTX -1.46%

BOLD -8.11%

BOLT 1.31%

BPMC -1.21%

BPTH 1.86%

BPTS -13.47%

BRNS -0.74%

BRTX -2.36%

BTAI 22.46%

BTTX 53.33%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.39%

CABA 0.48%

CADL -1.42%

CALA 0.00%

CALC -1.77%

CALT -0.59%

CAPR -2.80%

CARA 0.21%

CARM 13.08%

CASI -1.67%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -6.16%

CCCC -5.31%

CCXI 0.00%

CDAK 0.00%

CDIO -2.02%

CDIOW 24.00%

CDMO -2.84%

CDMOP 0.04%

CDT -10.57%

CDTTW -39.60%

CDTX -1.92%

CDXC 0.00%

CDXS 5.86%

CELC -4.25%

CELU -1.50%

CELUW 11.80%

CERC -1.68%

CERE -0.89%

CERO -4.50%

CEROW -10.18%

CFRX -27.95%

CGEM -2.25%

CGEN -3.85%

CGON -0.54%

CGTX -5.11%

CHMA -6.00%

CHRS -0.32%

CINC 0.00%

CING 2.56%

CINGW 34.95%

CKPT -2.87%

CLBS -16.75%

CLDX -2.47%

CLGN 0.34%

CLLS -4.15%

CLNN 2.42%

CLNNW 0.00%

CLRB 7.04%

CLSD 1.02%

CLSN -0.68%

CLVS 0.00%

CMMB -0.01%

CMND 3.63%

CMPI 0.00%

CMPX -7.50%

CMRA 0.00%

CMRAW 33.33%

CMRX -2.71%

CNCE 0.00%

CNSP -39.16%

CNST 0.00%

CNTA -0.67%

CNTB -2.25%

CNTX -6.85%

COCP -2.02%

COEPW 32.45%

COGT -3.00%

CORT 2.34%

COYA -1.46%

CPRX -0.99%

CRBP -1.98%

CRBU -5.10%

CRDF -2.20%

CRGX 0.67%

CRIS -0.38%

CRNX -5.90%

CRSP 0.93%

CRTX 2.63%

CRVO -2.50%

CRVS 1.12%

CSBR -1.59%

CTCX -1.63%

CTIC 0.06%

CTMX -3.31%

CTNM -1.35%

CTXR 2.03%

CUE 3.53%

CVAC -2.54%

CVKD -5.23%

CWBR 2.80%

CYAD -12.96%

CYCC 9.38%

CYCCP 5.49%

CYCN 0.43%

CYT -2.27%

CYTK -1.89%

CYTO -2.73%

DARE 6.41%

DAWN 0.52%

DBTX -0.81%

DBVT 4.44%

DFFN 10.28%

DICE 0.06%

DMAC 33.78%

DNLI -1.43%

DNTH -6.35%

DOMH -1.58%

DRMA -1.10%

DRMAW -1.25%

DRNA 0.00%

DRTS 1.85%

DRTSW 0.00%

DRUG 0.95%

DSGN -1.21%

DTIL 0.31%

DYAI 9.68%

EARS -1.77%

EDIT -2.52%

EDSA -1.00%

EFTR 8.18%

EFTRW -51.85%

EIGR -9.21%

ELAB -1.00%

ELDN 7.98%

ELEV -5.37%

ELOX 7.69%

ELTX -0.88%

ELVN -4.05%

ELYM 1.74%

ENGN 0.61%

ENGNW 0.12%

ENLV 2.54%

ENOB 1.79%

ENSC 4.13%

ENTA -0.49%

ENTO -4.42%

ENTX 0.69%

ENVB 1.10%

EPIX -0.10%

EPRX -2.97%

EPZM 0.00%

EQ 0.86%

EQRX -2.09%

EQRXW 0.00%

ERAS -1.44%

ERNA 0.00%

ERYP 1.30%

ESLA 4.30%

ESLAW 87.05%

ETNB -1.02%

ETON 1.68%

ETTX 0.00%

EVAX -2.14%

EVGN 3.88%

EVLO 0.00%

EWTX 0.00%

EXAI -0.58%

EXEL -0.36%

EYEG -0.69%

EYEN 1.48%

EYPT -0.12%

FATE -7.66%

FBIO 0.59%

FBIOP 0.92%

FBLG -14.30%

FBRX -0.04%

FDMT -4.86%

FENC -0.97%

FGEN -5.13%

FHTX 2.10%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -2.58%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE -0.18%

FULC -3.34%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -6.28%

GANX -1.49%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -4.31%

GHRS -1.59%

GLMD -2.32%

GLPG -2.26%

GLSI 2.80%

GLTO -0.57%

GLUE -2.36%

GLYC -10.72%

GMAB -0.43%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -2.92%

GNLX 1.33%

GNPX 0.00%

GNTA 3.94%

GOSS -9.80%

GOVX 7.50%

GOVXW -49.04%

GPCR -6.51%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -0.08%

GRTX 0.00%

GTHX 0.68%

GUTS -5.31%

GXGXW 41.67%

GYRE -7.16%

HALO -1.22%

HARP 0.09%

HCWB -3.75%

HEPA 2.80%

HGEN -84.62%

HILS 5.66%

HLVX -0.57%

HOOK 0.80%

HOTH -2.70%

HOWL -2.14%

HRMY 0.85%

HRTX 2.79%

HSTO 0.00%

HUMA 0.81%

HUMAW -0.01%

IBRX -3.86%

ICCC 0.22%

ICPT 0.21%

ICU 16.49%

ICUCW 20.20%

ICVX -0.91%

IDRA -23.04%

IDYA -2.07%

IFRX -1.85%

IGMS -0.15%

IKNA 0.30%

IKT 1.42%

IMAB -0.58%

IMCR -2.62%

IMGN 0.02%

IMGO 0.00%

IMMP 4.55%

IMMX -6.90%

IMNM -1.60%

IMNN 0.88%

IMPL -27.27%

IMRA 15.96%

IMRN -1.18%

IMRX 0.00%

IMTX -1.50%

IMTXW 6.00%

IMUX 1.56%

IMV 0.00%

IMVT -3.63%

INAB 0.00%

INBX 0.53%

INCY -0.82%

INDP 11.07%

INFI -52.38%

INKT -0.01%

INM 1.00%

INMB 3.01%

INO -2.21%

INSM -0.90%

INTS -2.75%

INVA 0.22%

INZY 0.92%

IOBT -11.42%

IONS 0.38%

IOVA -2.31%

IPA 2.46%

IPHA 5.58%

IPSC -2.15%

IRON -2.65%

ISEE 0.38%

ITOS -1.50%

ITRM 1.67%

IVA 6.96%

IVVD -3.72%

JAGX 1.05%

JANX -4.07%

JAZZ -0.66%

JNCE 0.00%

JSPR -5.93%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.94%

KALV -1.95%

KDNY 0.22%

KMPH -0.34%

KNSA -2.80%

KNTE -0.38%

KOD -7.11%

KPRX 0.96%

KPTI -1.83%

KRBP -10.00%

KRON 1.05%

KROS -1.20%

KRRO -6.34%

KRTX 0.03%

KRYS -0.90%

KTRA 17.72%

KTTA 8.16%

KTTAW 0.92%

KURA -1.83%

KYMR -2.41%

KYTX -5.13%

KZIA 5.16%

KZR -1.49%

LABP 0.57%

LBPH -1.70%

LBPS 0.00%

LBPSW 14.81%

LEGN 2.02%

LENZ -3.36%

LEXX 0.00%

LEXXW -14.63%

LGND -1.30%

LGNDV 0.00%

LGVN -9.61%

LIAN -8.28%

LIFE 2.70%

LIPO -7.10%

LIXT -5.24%

LIXTW 63.57%

LJPC -0.32%

LMNL 0.12%

LOGC 0.61%

LPCN -4.05%

LPTX -1.10%

LQDA -0.16%

LRMR -1.92%

LSTA -4.06%

LTRN 1.76%

LUMO -1.32%

LVTX 0.00%

LXEO -4.33%

LXRX -2.06%

LYEL -34.56%

LYRA 2.33%

MACK 0.10%

MBIO -9.32%

MBRX -1.72%

MCRB 1.23%

MDGL -2.70%

MDNA -13.16%

MDWD 0.10%

MDXG -2.58%

MEIP -0.13%

MESO -1.78%

MGNX -3.03%

MGTA -7.74%

MGTX -3.77%

MGX -2.68%

MIRM -1.80%

MIRO 0.59%

MIST 1.54%

MITO 0.00%

MLEC -7.69%

MLECW 2.31%

MLND -5.36%

MLTX -0.63%

MLYS -5.73%

MNKD -1.00%

MNMD 0.14%

MNOV 2.11%

MNPR -5.01%

MOLN 0.28%

MOR 1.29%

MORF -3.86%

MREO -5.00%

MRKR 2.68%

MRNA -4.90%

MRNS -4.04%

MRSN -2.86%

MRTX -0.17%

MRUS 0.04%

MRVI -1.82%

MTCR -1.29%

MTEM 4.46%

MTP -18.50%

MURA -1.24%

MYMD 8.38%

NAMS 1.37%

NAMSW 0.43%

NAUT 1.15%

NBRV 0.71%

NBSE -1.56%

NBTX 8.61%

NCNA 1.09%

NERV -1.90%

NEXI 2.60%

NGM -1.28%

NGNE -2.03%

NKGN 6.78%

NKGNW 8.00%

NKTR -4.21%

NKTX -4.57%

NLSP -2.82%

NLSPW 26.67%

NMRA -1.48%

NMTR -42.97%

NOVN -24.84%

NRBO 12.08%

NRIX -0.39%

NRSN -7.05%

NRSNW 0.00%

NRXP -4.09%

NRXPW 18.33%

NRXS 4.82%

NTBL 5.06%

NTEC -12.45%

NTHI 0.00%

NTLA -6.16%

NTRBW -31.07%

NUVL -2.00%

NVAX -2.36%

NVCT 3.59%

NVIV -34.28%

NXTC -2.94%

NYMX -0.05%

OABI 0.13%

OABIW -10.06%

OBIO -3.19%

OBSV 0.00%

OCEA 0.00%

OCGN 3.81%

OCS -1.02%

OCUL -2.21%

OCUP 1.96%

ODT -4.27%

OKYO 1.51%

OLMA -5.45%

OMER -1.28%

OMGA 5.00%

ONCO 5.04%

ONCR -3.08%

ONCS 31.87%

ONCT -1.87%

ONCY 0.99%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT 3.09%

ORGS -2.07%

ORIC -3.56%

ORMP 16.22%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.81%

OVID -1.44%

OYST 0.00%

PALI -0.87%

PASG -1.30%

PBLA -7.50%

PBM -6.75%

PBYI 1.69%

PCSA 0.00%

PCVX -0.37%

PDSB -2.69%

PEPG 0.27%

PGEN -2.99%

PHAR 1.51%

PHAS 0.00%

PHAT -1.06%

PHIO -3.57%

PHIOW 36.47%

PHVS -7.22%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -1.10%

PLUR 6.01%

PMN 0.72%

PMVP -1.19%

PNT 0.16%

PPBT -4.26%

PRAX 0.63%

PRDS 0.93%

PRLD 0.00%

PROG -3.47%

PROK 0.00%

PRQR -0.01%

PRTA -2.65%

PRTC 0.49%

PRTG -0.50%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -6.04%

PSTX -1.16%

PTCT -0.28%

PTE -0.82%

PTGX -1.77%

PTIXW -49.04%

PULM 2.60%

PXMD 0.00%

PYPD 0.07%

PYXS 1.96%

QLGN -4.49%

QNCX 5.70%

QNRX 0.37%

QSI -11.23%

QSIAW -3.13%

QTTB -4.54%

QURE -0.22%

RAIN -1.63%

RANI 6.42%

RAPT -2.92%

RARE 1.41%

RCKT -7.75%

REGN -0.70%

RENB -3.42%

REPL -2.50%

RETA 0.02%

REUN -0.89%

REVB -1.40%

REVBU 3.46%

REVBW 4.38%

RGLS -4.91%

RGNX -5.36%

RIGL -3.28%

RLAY -4.75%

RLMD 0.33%

RLYB 0.00%

RNA -0.56%

RNAC -4.78%

RNAZ -0.96%

RNXT 1.88%

ROIV -1.94%

ROIVW 4.56%

RPHM 0.00%

RPRX -0.06%

RPTX -2.64%

RUBY 2.70%

RVLP -32.05%

RVMD -1.29%

RVMDW -30.00%

RVNC 2.52%

RVPH -1.58%

RVPHW 1.62%

RXDX 0.09%

RXRX -3.20%

RYTM -6.51%

RYZB 0.02%

RZLT 2.08%

SABS -1.37%

SABSW -11.81%

SAGE 1.56%

SANA -3.96%

SAVA -0.43%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 5.50%

SCPH 0.51%

SCPS 0.00%

SEEL -4.48%

SEER -0.29%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -1.23%

SGMT -1.69%

SGTX -2.56%

SIOX 22.63%

SLDB -7.24%

SLGL 4.00%

SLN -4.21%

SLNO -4.03%

SLRX 6.04%

SLS -2.58%

SMMT -2.99%

SNDX 0.77%

SNGX -4.17%

SNPX -0.81%

SONN -1.08%

SPPI -0.49%

SPRB 0.32%

SPRC -4.17%

SPRO 0.30%

SRNE -34.00%

SRPT -1.38%

SRRA 0.00%

SRRK -2.85%

SRZN -2.45%

STAB 0.00%

STOK -5.29%

STRO -2.76%

STSA 0.00%

STTK -4.78%

SURF -0.93%

SVRA -3.29%

SWTX 0.34%

SYBX -1.94%

SYRS -1.72%

TALS -0.73%

TARA -7.62%

TARS -0.58%

TBPH 0.60%

TCBP 2.73%

TCDA 0.00%

TCON -1.35%

TCRR 0.00%

TCRT 1.59%

TCRX 2.83%

TECH -0.14%

TENX -1.27%

TERN -7.86%

TFFP -3.05%

TGTX -2.92%

THRX 0.12%

TIL -0.20%

TLC 0.00%

TLSA -3.09%

TNGX -2.89%

TNXP -6.39%

TNYA -7.17%

TPST 2.66%

TRDA -3.93%

TRVI 1.15%

TRVN 2.92%

TSHA -24.52%

TSVT -2.79%

TTNP -9.27%

TVTX 0.63%

TYRA -6.95%

UBX -2.12%

UNCY -2.43%

URGN -0.73%

UTHR -0.39%

VACC 11.36%

VALN -2.89%

VAXX 76.47%

VBIV 0.78%

VBLT -8.77%

VCEL 0.09%

VCNX 10.35%

VCYT -1.23%

VERA -2.78%

VERU 0.79%

VERV -2.96%

VIGL 5.11%

VINC 1.62%

VIR 0.54%

VIRI -1.57%

VIRX 2.40%

VKTX -1.67%

VLON -13.04%

VNDA -2.28%

VOR -2.02%

VRCA -0.07%

VRDN -4.31%

VRNA -1.33%

VRPX 0.38%

VRTX 0.39%

VSTM -3.58%

VTGN -0.45%

VTVT -2.97%

VTYX 0.00%

VXRT -2.88%

VYGR -1.53%

VYNE -3.47%

VYNT 7.78%

WINT -3.24%

WVE -4.51%

XBIO 0.93%

XBIT 1.77%

XCUR 3.58%

XENE -2.85%

XERS 2.38%

XFOR 2.09%

XLO 2.00%

XLRN 0.00%

XNCR 0.47%

XOMA -3.57%

XOMAO 0.36%

XOMAP -0.82%

XRTX -8.92%

YMAB -1.80%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -3.29%

ZNTL -2.38%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-06-12	Baker Bros. Advisors Lp	Buy	2 830	Common Stock
2024-06-12	Baker Bros. Advisors Lp	Sell	5 283 206	Common Stock
2024-06-12	Baker Bros. Advisors Lp	Buy	2 830	Common Stock
2024-06-12	Baker Bros. Advisors Lp	Sell	175 977	Common Stock
2024-06-12	Baker Bros. Advisors Lp	Buy	12 517	Non- Qualified Stock Options (right to buy)

INSIDER POWER
-77.59
Last 98 transactions
Buy: 962 698 \| Sell: 5 597 088

सहसंबंध (AI algo v.1.1b): Undervalued: 0.19% $62.68 paired level. (एल्गो वास्तविक समय में सबसे अधिक सहसंबंधित स्टॉक्स के परिवर्तनों का ट्रैक करता है और तत्काल अद्यतन देता है)

मात्रा सहसंबंध

लंबा: 0.72 (moderate)

छोटा: 0.77 (moderate)

Signal:(58) Neutral

Incyte Corp सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध
ADPT	0.947
NDLS	0.938
NEOG	0.928
RNW	0.928
BIGC	0.926
CWCO	0.924
DCFC	0.923
MAXN	0.923
CLNE	0.922
NVTS	0.922

10 सबसे अधिक नकारात्मक सहसंबंध
SWAV	-0.903
TAYD	-0.895
IVCB	-0.887
BCSA	-0.887
FTGC	-0.883
JVA	-0.882
KINS	-0.88
MTEK	-0.873
EML	-0.871
LPCN	-0.869

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Incyte Corp सहसंबंध - मुद्रा/वस्त्र

0.22
( neutral )

-0.21
( neutral )

0.00
( neutral )

0.32
( neutral )

0.00
( neutral )

-0.67
( moderate negative )

Incyte Corp वित्तीय

Annual	2023
राजस्व:	$3.70B
सकल लाभ:	$3.44B (93.10 %)
EPS:	$2.67

FY	2023
राजस्व:	$3.70B
सकल लाभ:	$3.44B (93.10 %)
EPS:	$2.67

FY	2022
राजस्व:	$3.39B
सकल लाभ:	$3.19B (93.90 %)
EPS:	$1.530

FY	2021
राजस्व:	$2.99B
सकल लाभ:	$2.84B (94.94 %)
EPS:	$4.30

Financial Reports:

No articles found.

Incyte Corp Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Incyte Corp

Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as oncogenic drivers in various liquid and solid tumor types; and ICLUSIG, a kinase inhibitor to treat chronic myeloid leukemia and philadelphia-chromosome positive acute lymphoblastic leukemia. Its clinical stage products include ruxolitinib, a steroid-refractory chronic graft-versus-host-diseases (GVHD); itacitinib, which is in Phase II/III clinical trial to treat naïve chronic GVHD; and pemigatinib for treating bladder cancer, cholangiocarcinoma, myeloproliferative syndrome, and tumor agnostic. In addition, the company engages in developing Parsaclisib, which is in Phase II clinical trial for follicular lymphoma, marginal zone lymphoma, and mantel cell lymphoma. Additionally, it develops Retifanlimab that is in Phase II clinical trials for MSI-high endometrial cancer, merkel cell carcinoma, and anal cancer, as well as in Phase II clinical trials for patients with non-small cell lung cancer. It has collaboration agreements with Novartis International Pharmaceutical Ltd.; Eli Lilly and Company; Agenus Inc.; Calithera Biosciences, Inc; MacroGenics, Inc.; Merus N.V.; Syros Pharmaceuticals, Inc.; Innovent Biologics, Inc.; Zai Lab Limited; Cellenkos, Inc.; and Nimble Therapeutics, as well as clinical collaborations with MorphoSys AG and Xencor, Inc. to investigate the combination of tafasitamab, plamotamab, and lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma, and relapsed or refractory follicular lymphoma. The company was incorporated in 1991 and is headquartered in Wilmington, Delaware.